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INTRODUCTION
Coordination polymers are described as a 
compound that joins metal ions through organic 
moieties (linkers) in one, two, or three dimensions.1 
Metal-organic frameworks (MOFs) are a class of 
coordination polymers that possess permanent 
porosity that can be applied in molecular recogni-
tion and separation, gas storage, catalysis, sensing, 
drug delivery, display technologies, luminescence, 
and biomedical imaging.15,5,11,8 MOFs with lumines-
cence and bioimaging properties in the nanoscale 
size are currently being studied for promising use in 
biomedical imaging.12 
Although MOFs have only been extensively 
studied for about fifteen years, there are many publi-
cations that describe compound synthesis and char-
acterization, with increasing attention on the syn-
thesis of MOFs in the nanometer scale.12,7 William 
et al. report that the majority of nano-sized imaging 
entities are constructed by inorganic materials only, 
including quantum dots, superparamagnetic metal 
oxides, and gold nanoparticles.12 MOFs differ from 
these compounds in not only the presence of an 
organic component, but also their porosity that can 
be potentially used for combined imaging and drug 
delivery, known as theranostics8. 
With an interest in developing MOFs for bio-
imaging purposes, trivalent lanthanides (Ln) are an 
ideal selection as the inorganic metal cation in the 
construction of nanoMOFs (nMOFs). Ln centers 
allow for multimodal imaging; europium (Eu) and 
terbium (Tb) provide visible luminescence upon 
excitation by ultraviolet (UV) radiation, which can 
be differentiated from natural biological auto-flu-
orescence due to the relatively long luminescence 
lifetimes of Ln ions.9 Lanthanides also possess 
magnetic properties, especially gadolinium (Gd) 
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This study focuses on the solvothermal synthesis of two lanthanide-based coordination poly-
mer/metal-organic framework systems assembled from 1,3,5-benzenetricarboxylic acid (BTC) in 
the nano-sized regime for use as bioimaging agents. These materials were synthesized using two 
different lanthanide ions, a luminescent center (Eu, Tb) for optical imaging purposes and Gd, 
whose magnetic properties are particularly beneficial in magnetic resonance imaging (MRI) as 
a contrast agent. Together, these two features allow for multimodal imaging, useful in the study 
and diagnosis of disease. Under identical reaction conditions, two different compounds were 
formed upon changing the identity of the optically active lanthanide metal ion. Compound 1 
([EuGd(BTC)2(H2O)12]) emerged as a one dimensional coordination polymer, increasing in size 
with reaction time; while compound 2 ([TbGd(BTC)2(H2O)2]n•2DMF) emerged as a three dimen-
sional framework, decreasing in size with time. Both compounds displayed vibrant luminescence 
upon UV excitation, indicating potential as bioimaging agents.
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that has seven unpaired electrons. This large num-
ber of unpaired electrons creates a large magnetic 
response that allows for their use as magnetic reso-
nance imaging (MRI) contrast agents.4 The design 
of MRI contrast agents requires a magnetic metal 
ion, one or more coordinated and exchangeable 
aqua (water) ligands, and high stability in biological 
media. Currently, the United States Food and Drug 
Administration (FDA) has only a small number of 
approved Gd-based MRI contrast agents and devel-
oping new and better contrast agents is an active 
area of research.3,10 As the ionic radii across the Lns 
are very similar, it is facile to incorporate several dif-
ferent Ln ions in one material. This feature can pro-
vide different functionalities into one compound, 
such as the aforementioned optical and magnetic 
properties to produce multimodal imaging. Ln 
nMOFs can be synthesized with varying numbers of 
exchangeable aqua ligands, a feature that is good for 
MRI. Ln nMOF’s porosity also provides an alterna-
tive platform than current methods for drug loading 
and delivery that combined with imaging could lead 
to the development of theranostic nMOFs. 
Before nMOFs can be utilized for theranostic 
applications, however, more fundamental research 
into nMOF structure-property relationships is nec-
essary. There is still little known about how nMOF 
structure, composition, dimensionality, particle 
size, and particle morphology affect imaging prop-
erties, particularly concerning MRI. The goal of 
our research is to understand how these factors 
contribute to observed luminescent and magnetic 
responses of nMOF materials. The overall goal of 
this project is to synthesize nMOFs with both opti-
cally and magnetically active Ln ions to produce 
new multimodal bioimaging agents, and preliminary 
findings toward this goal are presented herein.
NanoMOFs compounds 1 and 2 were syn-
thesized through the solvothermal reaction of lan-
thanide salts with an organic linker.4,6 A 1:2 Eu/Gd 
(1) and Tb/Gd (2) system were synthesized, where 
Eu and Tb allow for optical imaging and Gd brings 
paramagnetic properties necessary for MRI. It was 
observed that two different compounds were formed 
depending on whether Eu or Tb was used during 
the synthesis, compound 1= [EuGd(BTC)2(H2O)12]n 
and compound 2= ([TbGd(BTC)2(H2O)2]n•2DMF). 
(BTC= 1,3,5-benzenetricarboxylic acid, or trimesic 
acid; DMF= N,N’-dimethylformamide). Synthesis, 




Compounds 1 and 2 were synthesized via sol-
vothermal methods in a 23 mL Teflon lined Parr 
bomb. A 1:2 Ln/Ln (Ln= Eu/Gd or Tb/Gd) mix of 
the selected lanthanide chloride salts, sodium tri-
fluoroacetate (NaTFA), and BTC were mixed in a 
~1:0.9:0.6 Ln:TFA:BTC ratio (21.0 mg of BTC, 0.10 
mmol) with the solvents water (H2O, 4 mL) and 
DMF (8 mL). The bombs were sealed and heated at 
60 oC for 24-72 hours. Once the reactions were com-
pleted, the Parr bombs were removed from the oven 
and allowed to cool to room temperature. After 
approximately 30 minutes, the bombs were opened 
and a clear, colorless liquid with a small white solid 
were observed. The compounds were isolated via 
centrifugation at 15,000 rpm for 5 minutes, followed 
by ethanol washes with sonication (five minutes) 
and allowed to air dry.
Dynamic Light Scattering (DLS) is a tech-
nique used for particle size characterization in col-
loidal dispersions.6 Once the synthesized samples 
were cleaned and dried, DLS measurements were 
performed to estimate nMOF size. Approximately 
5-10 mg of nMOF were suspended in an aqueous 
colloid (~10 mL H2O) and sonicated for five minutes 
just before DLS analysis on a Malvern Zetasizer. See 
Tables 1 and 2 for a summary of nMOF size versus 
reaction time.
Structural characterization was performed on 
synthesized nMOFs using powder X-ray diffraction 
(PXRD) on an Olympus Scientific BTX II Powder 
X-ray Diffractometer (Co source, 5-55o 2θ). PXRD 
patterns were matched to known compounds 
reported in the Cambridge Structural Database 
(CSD) (Figures 1 and 2) through the Cambridge 
Crystallographic Data Centre. This is a database of 
over 800,000 crystal structures reported through-
out the literature. This database essentially contains 
every known crystal structure of compounds con-
taining C-C bonds, with the exception of large mac-
romolecules and biomolecules. PXRD data can be 
compared to data contained in this database to iden-
tify the synthesis of previously reported structures. 
Luminescence spectra were collected on a 
Perkin Elmer LS55 Fluorescence Spectrometer at 
room temperature (23 ± 2 °C) on both solid sam-
ples in a PMMA matrix (2 mg of sample ground in 
10 mg of PMMA) and aqueous suspensions (~5-10 
mg in ~10 mL DI water followed by 5 minutes of 
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sonication). Excitation spectra were collected at the 
maximum emission wavelength of Eu (615 nm, 1) 
or Tb (545 nm, 2), and emission spectra were then 
recorded at the maximum excitation wavelength 
(~250-300 nm, compound and phase (solid/colloid 
suspension) dependent). 
Preliminary relaxivity data were collected on 
all compounds, and the data is provided in Table 3. 
Approximately 0.1 mM aqueous solutions of each 
nMOF compound were prepared in DI water and 
sonicated for five minutes. The colloidal suspen-
sions were then placed in a bench top 43 MHz (1T) 
field Magritek Spinsolve 60 NMR spectrometer. 
Relaxometry measurements were then conducted to 
determine T1/T2 relaxation times for each system.
RESULTS
An opposite relationship in particle growth 
versus time between the two compounds was 
observed (Tables 1 and 2). Compound 1 depicted 
particle size increase with time, whereas compound 
2 showed an opposite trend decreasing in size with 
time, and reaching a plateau after 72 hours. PXRD 
was used to identify compound 1 as RAVJUV and 
compound 2 as YEMJAC in the CSD.
The 48 hours samples (ASG 2-21 and ASG 
1-67) of compound 1 and compound 2, respectively, 
were analyzed using fluorescence spectroscopy, and 
both compounds display vibrant luminescence upon 
UV excitation (Figure 3) in both the solid state and 
in aqueous colloidal solutions. The broad excitation 
profile of 1 and 2 is indicative of absorption of the 
Figure 1. PXRD pattern (horizontal trace) of 1 (reaction time = 48 hours) compared to RAVJUV 
in the CSD (vertical lines)
Figure 2. PXRD pattern (horizontal trace) of 2 (reaction time = 48 hours) compared to YEMJAC 
in the CSD (vertical lines). 
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Figure 3. Excitation (~200-300 nm) and emission (~450-650 nm) spectra of solid (left) and colloi-
dal solutions (right) of 1 (top) and 2 (bottom).
Figure 4. Structure of compound 1 down the [001] direction (left). Polyhedra represent LnO9, 
spheres are oxygen (O) atoms, and black lines are carbon (C) atoms. Hydrogen (H) atoms have been 
omitted for clarity. Local Ln (Ln = Gd here) coordination sphere is shown in the middle to highlight the 
six bound water molecules/Ln, and the view down [101] shows the individual chains (right).
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organic BTC component. The BTC absorbs UV 
radiation and transfers this energy to the Ln ion 
to sensitize luminescence in a process commonly 
referred to as the “antenna effect.”2 Upon excitation 
of the BTC, red Eu and green Tb emission is seen, 
with minimal background fluorescence from the 
BTC linker, indicating efficient energy transfer and 
sensitization. The bright emission is easily seen with 
the naked eye, essential for use as potential bioim-
aging agents.
Preliminary measurements of relaxation times 
(Table 3) indicate that the title compounds do show 
an increase in relaxation of water protons with 
relaxivities comparable to those of some currently 
used Gd-based contrast agents13, but direct compar-
isons and consequences of these data require more 
detailed studies that are planned. Full characteriza-
tion of the magnetic properties of the compounds 
have yet to be assessed, however, and will be the 
focus of future work, as will cell and tissue imaging 
studies. It is clear though that nMOFs 1 and 2 show 
promise as MRI contrast agents, though the lack of 
a clear trend between relaxivity and nMOF size is 
surprising. This could be due to a combination of 
size, shape, and/or water diffusion rate effects, but 
additional studies including electron microscopy 
will be required to explore this further. 
DISCUSSION
The overall purpose of this study was to study 
nMOF formation and growth in order to assess 
their use as potential bioimaging and MRI con-
trast agents. While many MOF structures can be 
synthesized using any of the lanthanides, in some 
instances the lighter Lns will produce a different 
compound than the heavier Lns under otherwise 
identical reaction conditions. This was observed 
in the targeted system under study in which Eu/Gd 
formed a highly hydrated, 1-dimensional compound, 
and Tb/Gd formed a 3-dimensional, porous frame-
work. This serendipitous discovery was fortunate 
and provides two contrasting compounds for future 
imaging studies, one system that contains six water 
Figure 5. Structure of compound 2 down [001]. See caption of Figure 4 for atom description details. 
Note only one bound water molecule/Ln here. 
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molecules/Ln center (compound 2), and the other 
with one water molecule/Ln center (compound 1), 
identical to the MRI contrast agents in current clin-
ical use that consist of Gd-based molecules with one 
water molecule/Ln.
STRUCTURAL DESCRIPTION
Compound 1 is composed of LnO9 mono-
mers that extend through fully deprotonated BTC 
linkers into 1-dimensional chains. The Ln coordi-
nation sphere is composed of three monodentate 
linkages from the deprotonated BTC carboxylate 
oxygen atoms and six aqua ligands. The chains are 
densely packed and run parallel to one another in a 
staggered fashion, shown in Figure 4.
Compound 2 is a three-dimensional framework 
assembled from LnO7 polyhedra linked together by 
fully deprotonated BTC linkers (Figure 5). The Ln 
is coordinated through monodentate linkages to 
carboxylate oxygen atoms from six distinct BTC 
moieties, with one coordinated water molecule to 
fulfill the coordination sphere. The BTC assemble 
the monomers into a framework that has residual 
DMF solvent molecules residing in the pores of the 
compound (not depicted in Figure 5). 
Another interesting observation was the 
opposite relationship in particle growth versus 
time between the two compounds (Tables 1 and 2). 
In 1, particle size increased with time as expected 
through typical crystal growth and Oswald ripen-
ing processes. The opposite was found to be true 
in 2, where particle growth decreased with increas-
ing time. This has been observed in other nMOF 
systems,4,14 but is not well understood. This may 
be due to the differences in dimensionality (1-D 
in 1 versus 3-D in 2) between the two systems, but 
further investigations are required to confirm this 
conjecture.
CONCLUSION
In conclusion, two nMOFs systems were syn-
thesized and characterized. It was observed that 
changing the visible emitting Ln ion from Eu to Tb 
resulted in a significant structural change from a 
1-dimensional compound to a 3-dimensional frame-
work. Particle size versus reaction time followed 
opposite trends, where 1 increased in size over 
time whereas 2 decreased in size as reaction time 
increased, contrary to typical nanoparticle crystalli-
zation mechanisms. Both 1 and 2 displayed vibrant 
red and green (respectively) emission upon UV exci-
tation, indicating potential for bioimaging applica-
tions. Preliminary relaxometry measurements indi-
cate that the nMOFs show promise as MRI contrast 
agents, though further characterization is necessary 
to fully understand the magnetic responses of the 
compounds. Upon optimization of reaction condi-
tions, nMOFs structure and size were successfully 
manipulated to provide the materials necessary for 
future bioimaging studies.
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Table 3. Results of relaxometry measurements to produce T1 and T2 relaxation times and relax-
ivity rates, r1 and r2.
Compound Sample Name Size (nm) T1 (s) T2 (s) r1 (mM-1s-1) r2 (mM-1s-1)
1 ASG 2-11 681 2.85 2.50 3.51 4.00
1 ASG 2-21 1172 2.81 2.27 3.56 4.41
1 ASG 2-17 1374 3.11 2.69 3.21 3.72
2 ASG 2-07 634 2.96 2.51 3.38 2.96
2 ASG 1-67 562 2.89 2.58 3.88 2.58





Mean diameter   
(nm)
ASG 2-7 24 634 ± 24
ASG 1-67 48 562 ± 17
ASG 1-93 72 415 ± 7





Mean diameter   (nm)
ASG 2-11 24 681 ± 34
ASG 2-21 48 1172 ± 253
ASG 2-17 72 1374 ± 104
Table 1. DLS Results of Compound 1 
TABLES
